2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Co-Argi-Peg: new trials by email Literature Review of Co-Argi-Peg trials Research Report on Co-Argi-Peg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AEB1102 (Pegzilarginase) in Patients With Arginase 1 Deficiency AEB1102 - Arginase I Deficiency, Hyperargininemia | Phase 2 | Completed | Immedica Pharma AB | 14 | 2017-12-07 | 2026-09-24 |
| A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency AEB1102 - Arginase I Deficiency, Hyperargininemia | Phase 1 / Phase 2 | Completed | Aeglea Biotherapeutics | 16 | 2016-06-01 | 2019-06-12 |
Hyperargininemia (2)
Aeglea Biotherapeutics (1) · Immedica Pharma AB (1)
Canada (2) · Portugal (2) · United Kingdom (2) · United States (2)
Josie Gayton (1) · Mattias Rudebeck, PhD MSc BMedSc (1)